000 01209 a2200337 4500
005 20250517161723.0
264 0 _c20181105
008 201811s 0 0 eng d
022 _a1878-5832
024 7 _a10.1016/j.drudis.2017.06.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTsigkos, Stelios
245 0 0 _aEstablishing rarity in the context of orphan medicinal product designation in the European Union.
_h[electronic resource]
260 _bDrug discovery today
_cMar 2018
300 _a681-686 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aDrug Approval
_xlegislation & jurisprudence
650 0 4 _aEuropean Union
650 0 4 _aHumans
650 0 4 _aLegislation, Drug
650 0 4 _aOrphan Drug Production
_xlegislation & jurisprudence
700 1 _aHofer, Matthias Philipp
700 1 _aSheean, Maria Elzbieta
700 1 _aMariz, Segundo
700 1 _aLarsson, Kristina
700 1 _aNaumann-Winter, Frauke
700 1 _aFregonese, Laura
700 1 _aSepodes, Bruno
773 0 _tDrug discovery today
_gvol. 23
_gno. 3
_gp. 681-686
856 4 0 _uhttps://doi.org/10.1016/j.drudis.2017.06.003
_zAvailable from publisher's website
999 _c27309367
_d27309367